PPARG and cancer: Several studies have suggested that the activation of peroxisome proliferator-activated receptor-γ (PPAR-γ) may be involved in cancer development in obesity, since it inhibits cell proliferation and induces apoptosis in vitro, possibly by antagonizing the activities of NF-κB [90].